Autoimmune Disease Diagnosis Market is anticipated to grow at a CAGR of 8.6% CAGR from 2019 to 2030.
Market Industry Reports (MIR) has published a new report titled “Autoimmune Disease Diagnosis Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the Global Autoimmune Disease Diagnosis Market is estimated to account for over US$ 3.5 billion in 2019. It is anticipated to grow at a CAGR of 8.6% CAGR from 2019 to 2030.
The steady growth of the autoimmune disease diagnosis market can be attributed to the rising incidences of autoimmune diseases worldwide, especially in the U.S., wherein, it is considered to be the major health crisis. According to Bingham Healthcare organization, more than 50 million Americans suffer from one or more autoimmune diseases. According to the Department of Health and Human Services’ Office of Women’s Health, autoimmune diseases and disorders are ranked in the first position in the top ten list. Along with its increase in awareness among people regarding autoimmune diseases through different research programs and education is helping people to treat the autoimmune diseases at early stage. Also, governments and NGOs are involved in creating awareness among people. Advancements in diagnostic technology along with improvements in laboratory automation are also driving market growth. Rising access to medical insurance will further boost market growth of the market significantly.
However, the high capital requirement in the development of the diagnostic tests and their slow turnaround times of the diagnosis will hamper market growth.
Asia Pacific is estimated to grow at the highest CAGR owing to the increasing prevalence of autoimmune diseases and growing awareness among people. In addition to this, developments in the healthcare sector in this region will lead to better accessibility to advanced technologies for the diagnosis of autoimmune diseases. As a result, the autoimmune disease diagnosis market is likely to expand in the region during the forecast period.
Browse key industry insights spread across 190 pages with market data tables & figures & charts from the report, Autoimmune Disease Diagnosis Market by Product & Services (Consumables & Assay Kits, Instruments, and Services), by Test Type (Routine Laboratory Tests, Inflammatory Markers, and Autoantibodies and Immunologic Tests), by Disease Indication (Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Sjögren’s Syndrome, Thyroiditis, and Scleroderma) and End-User (Clinical Laboratories and Hospitals) - Global Analysis & Forecast 2019-2030 in detail along with the table of contents:https://www.marketindustryreports.com/autoimmune-disease-diagnosis-market/212
Some of the prominent players in the global autoimmune disease diagnosis market include Siemens AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Hemagen Diagnostics, Inc., Bio-Rad Laboratories, Inc., GRIFOLS, S.A., Trinity Biotech Plc., Inova Diagnostics, Inc., HYCOR Biomedical, EUROIMMUN AG, and others.
Market Industry Reports is a global leader in market measurement and advisory services. It is a 100% subsidiary of ExlTech. The firm has always been at the forefront of innovations to address worldwide industry trends and opportunities. We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates consumer study in more than 100 countries, providing a tactical approach to drive sustained business growth. We continue to pioneer state-of-the-art approach in research & analysis that will help you to overcome complexities and stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence, we unfold contingencies for our clients in the evolving world of technology, mega-trends, and industry convergence. We inspire our clients to empower and shape their businesses and to build world-class products.